Improving lung cancer screening and smoking cessation for African Americans
Official title: Effectiveness of a multilevel integrated intervention for LDCT lung cancer screening and smoking cessation among African Americans
Funded at Lsu Health Sciences Center · NIH-10943504 · Data updated 2026-11-12
This study is looking for ways to make lung cancer screenings and quitting smoking easier and more effective for African Americans, who are at a higher risk for lung cancer, by combining special screenings with personalized support to help them stop smoking.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lsu Health Sciences Center NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project start | September 23, 2024 |
| Project end | June 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $401,715 |
| NIH project number | 1R01MD019690-01 |
| Project ID | NIH-10943504 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are African American adults aged 50-80 with a history of smoking.
✕Less likely to help
Patients who do not smoke or are not within the specified age range may not benefit from this research.
What this research studies
This research investigates how to enhance the effectiveness of lung cancer screening and smoking cessation programs specifically for African Americans, who face higher rates of lung cancer. The study will implement a multilevel integrated intervention that combines low-dose computed tomography (LDCT) screening with tailored support for quitting smoking. By engaging the community and addressing cultural factors, the research aims to improve participation in screenings and promote successful smoking cessation among African American smokers. The approach includes active follow-up and support to ensure adherence to both screening and cessation efforts.
Why it matters
Potential benefit: If successful, this research could significantly reduce lung cancer rates and improve health outcomes for African Americans by increasing screening uptake and smoking cessation.
How similar studies have gone: Previous research has shown that culturally tailored interventions can be effective in improving health outcomes in minority populations, suggesting potential success for this approach.
Where this research is happening
-
Lsu Health Sciences Center
New Orleans, United States Active
Researchers
- Principal investigator: Tseng, Tung Sung — Lsu Health Sciences Center
- Study coordinator: Tseng, Tung Sung
Related research
Other NIH-funded projects on the same topics.
-
Integrated approach to lung screening and quitting for African Americans
A multi-level program aims to boost LDCT lung cancer screening uptake and help African American smokers quit, with support from a comprehensive community-focused plan.
-
Personalized lung cancer risk tool to boost screening and help people quit smoking
This project uses a personalized risk profile to help current and former smokers—particularly underserved and African American patients—get lung cancer screening and stop smoking.
-
Improving lung cancer screening and smoking cessation for at-risk patients
This study is looking to help current and former smokers, especially those in underserved communities like African Americans, get better access to lung cancer screenings and support to quit smoking by using a special tool that helps doctors and patients talk about their lung cancer risks and treatment options in a more
-
Blood-based markers to identify lung cancer risk in never-smokers
A researchers team at NYU School of Medicine is testing blood tests that might flag higher lung cancer risk in people who have never smoked, helping decide who might need screening.
-
Social stress and smoking: why disadvantaged young adults struggle to quit
This grant looks at how daily social stress affects if and when disadvantaged young adults who smoke can quit and stay quit.
-
I-STOP: a mobile health program to help people with HIV quit smoking
A smartphone-based program designed to help people with HIV quit smoking in a sustainable, affordable way.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.